Nevertheless, the majority of non-small cell lung carcinomas (NSCLCs) are angiogenic and express vascular endothelial growth factor-A (VEGF) (Jubb et al, 2004), the predominant pro-angiogenic ligand that is exploited by tumours (Kerbel, 2008). The gene discussed is VEGFA; the disease is neoplasm.